ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195,905 | +640.7% | 9,561 | +618.3% | 0.00% | – |
| Q2 2023 | $26,447 | +26.8% | 1,331 | +9.3% | 0.00% | – |
| Q1 2023 | $20,864 | -10.3% | 1,218 | +2.5% | 0.00% | – |
| Q4 2022 | $23,249 | +16.2% | 1,188 | -7.1% | 0.00% | – |
| Q3 2022 | $20,000 | -9.1% | 1,279 | -21.3% | 0.00% | – |
| Q2 2022 | $22,000 | -86.6% | 1,625 | -84.2% | 0.00% | – |
| Q1 2022 | $164,000 | -17.6% | 10,284 | +12.6% | 0.00% | – |
| Q4 2021 | $199,000 | -14.6% | 9,134 | +17.3% | 0.00% | – |
| Q3 2021 | $233,000 | -10.7% | 7,790 | +32.3% | 0.00% | – |
| Q2 2021 | $261,000 | +16.0% | 5,888 | +16.0% | 0.00% | – |
| Q1 2021 | $225,000 | +1507.1% | 5,077 | +1891.0% | 0.00% | – |
| Q4 2020 | $14,000 | +366.7% | 255 | +125.7% | 0.00% | – |
| Q3 2020 | $3,000 | – | 113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |